A study of anti-tumor effect of the dendritic cells infected with HF10-packaged amplicon carrying tumor associated antigen
Project/Area Number |
15H06279
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Virology
|
Research Institution | Nagoya University |
Principal Investigator |
Luo Chenhong 名古屋大学, 医学系研究科, 招へい教員 (40759627)
|
Project Period (FY) |
2015-08-28 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | Glypican 3 / dendritic cells / Lamp-1 / signal peptide / アンプリコン / GCP / LAMP / 樹状細胞 / ウイルス / 腫瘍 / HF10 / GPC3 |
Outline of Final Research Achievements |
In this study, our results indicated that 1. HF10-package amplicon, which expresses tumor associated antigen glypican3 (GPC3), induced the antigen specific immune response through infected dendritic cells and inhibited the tumor growth in mouse ovarian cancer model. 2. In mouse peritoneal tumor seeding model, through prophylactic vaccination, we found that the dosing i.p. had the best antitumor effect among i.p., i.v., and s.c. dosing routes. 3. The chimera of Lamp-1 signal peptide and GPC3 induced GPC3 specific immune response through dendritic cell presentation more strongly than GCP3.
|
Report
(3 results)
Research Products
(9 results)
-
-
[Presentation] Systemic delivery strategy of oncolytic herpes simplex virus HF10 adsorbed on antigen-specific lymphocytes2016
Author(s)
Toru Ichinose, Chenhong Luo, Yusuke Koide, Wu Zhiwen, Nobuaki Mukoyama, Noriyuki Miyajima, Daishi Morimoto, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Maki Tanaka, Yasuhiro Kodera, Hideki Kasuya
Organizer
第22回日本遺伝子細胞治療学会学術集会
Place of Presentation
虎ノ門ヒルズフォーラム(東京都港区)
Year and Date
2016-07-28
Related Report
-
[Presentation] ENHANCED ANTI-TUMORAL ACTIVITY OF ONCOLYTIC HERPES SIMPLEX VIRUS HF10 WITH CETUXIMAB AGAINST HUMAN COLORECTAL CANCER2016
Author(s)
Zhiwen Wu, Toru Ichinose, Chenhong Luo, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Noriyuki Miyajima, Daishi Morimoto, Nobuaki Mukoyama, Yoko Nishikawa, Usuke Koide, Toshie Kuwahara, Yasuhiro Kodera, Maki Tanaka, Hideki Kasuya
Organizer
第22回日本遺伝子細胞治療学会学術集会
Place of Presentation
虎ノ門ヒルズフォーラム(東京都港区)
Year and Date
2016-07-28
Related Report
-
[Presentation] Combination therapy of squamous cell carcinoma mouse models with PD-L1 immune checkpoint inhibitor and oncolytic herpes simplex virus HF102016
Author(s)
Nobuaki Mukoyama, Toru Ichinose, Chenhong Luo, Yusuke Koide, Wu Zhiwen, Noriyuki Miyajima, Daishi Morimoto, Maki Tanaka, Yasushi Fujimoto, Michihiko Sone, Yasuhiro Kodera, Hideki Kasuya
Organizer
第22回日本遺伝子細胞治療学会学術集会
Place of Presentation
虎ノ門ヒルズフォーラム(東京都港区)
Year and Date
2016-07-28
Related Report
-
-
-
-
[Presentation] Combination therapy against human pancreatic cancer with oncolytic herpes virus hrR3 and monoclonal antibody bevacizumab2015
Author(s)
Zhiwen Wu, Toru Ichinose, Chenhong Luo, Gewen Tan, Tevfik T. Sahin, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Yoko Nishikawa, Usuke Koide, Saori Fukuda, Yasuhiro Kodera, Hideki Kasuya
Organizer
第74回日本癌学会学術総会
Place of Presentation
名古屋国際会議場 (愛知県名古屋市)
Year and Date
2015-10-08
Related Report
-